Blood Protein Could Help Detect Advanced CTE
If larger studies confirm it, a blood test could one day help people with repeated head trauma be checked for CTE while still alive.
Updated on Nov. 14, 2026 in Alzheimer’s

Live Poll
Would knowing a blood test could detect brain damage change whether you let your child play contact sports?
Researchers at Washington University School of Medicine in St Louis identified a blood protein fragment, eMTBR-tau243, that is elevated in people with advanced chronic traumatic encephalopathy (CTE), a brain disease caused by repeated head trauma. The finding, published in JAMA Neurology, suggests a blood test could one day help diagnose CTE in living patients, including those with a history of contact sports.
Why it matters
CTE can currently be confirmed only after death through examination of brain tissue, leaving living patients and their clinicians without a way to measure the disease. A validated blood test would open the door to earlier identification and to monitoring of people at risk, and it could make clinical trials of potential treatments possible.
The study measured blood levels of the protein fragment eMTBR-tau243 in 11 people whose CTE was confirmed at autopsy, compared with healthy participants. The test separated advanced CTE from healthy people with high accuracy, but it does not yet detect early-stage disease and has not been validated for diagnosis.
The players
Washington University School of Medicine
A leading academic medical center in St Louis with research programs in neurology and neurodegenerative disease, including work on Alzheimer's and related brain conditions.
JAMA Neurology
A peer-reviewed medical journal published by the American Medical Association that covers research on diseases of the brain and nervous system.
Professional Footballers' Association
The trade union representing professional soccer players in England, which has recommended limits on heading the ball to reduce risks linked to brain injury.
The details
CTE develops when repeated trauma to the head triggers a buildup of toxic tau protein in the brain, the same type of protein buildup seen in Alzheimer's disease and other brain conditions. The researchers focused on eMTBR-tau243, a fragment of that tau protein, which appears in the blood and rises as brain disease becomes more severe. Because the fragment can be measured in a simple blood sample, it offers a potential route to detecting the disease that currently requires examining brain tissue after death.
Timeline
Earlier this year, the Professional Footballers' Association recommended limits on heading a ball, including a maximum of 10 times a week in training.
On November 14, 2026, the study identifying the blood biomarker for advanced CTE was reported in JAMA Neurology.
Health Landscape
Diagnosis of CTE has depended on post-mortem brain examination, which has left the scale of the condition in living athletes largely unmeasured. A blood marker that tracks disease severity would be a significant shift if larger studies validate it, since it could support both clinical monitoring and the testing of potential treatments.
If you have a history of repeated head impacts from contact sports or other activities, it is worth discussing head-injury history and any cognitive changes with your doctor. This research is at an early stage, so no blood test for CTE is available for routine use today.
The takeaway
The key insight is that a blood marker may eventually let clinicians detect CTE in living people rather than only after death. Anyone concerned about repeated head trauma should talk with a physician about symptoms and history, and should follow larger studies that test whether the blood measure holds up.
Further reading
For more background on the brain disease that shares protein buildup with CTE, explore our coverage of Alzheimer's research in the United States.
Live Poll
Would knowing a blood test could detect brain damage change whether you let your child play contact sports?





